Early Diagnosis and Individualized Management of Focal Seizures in the Intensive Care Unit

Title:

Early Diagnosis and Individualized Management of Focal Seizures in the Intensive Care Unit

Topic: Neurology
Primary Audience: This activity is intended for physicians, nurses, pharmacists and other providers involved in managing patients with focal seizures in the ICU.
Launch Date: 18-Jul-17
Credits: 0.5 AMA PRA Category 1 Credit
0.5 ACPE contact hour
0.5 ANCC contact hour
Expiration Date: 17-Jul-18
Curriculum Name: Seizures in the Intensive Care Unit (ICU)

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Identify and manage ICU patients that are at risk for seizures
  2. Compare the individual agents, pharmacokinetics, adverse events, and dosing considerations to create individualized treatment plans for epilepsy

    Faculty

    Selim R. Benbadis, MD
    Professor of Neurology and Director, 
    Comprehensive Epilepsy
    University of South Florida and Tampa General Hospital
    Stephen Hantus, MD  
    Clinical Assistant Professor of Medicine
    Director of the Continuous Electroencephalogram (EEG) monitoring and Epilepsy Consult Service
    Cleveland Clinic Epilepsy Center
    Cleveland, Ohio
    CME Credit provided by The Society of Critical Care Medicine (SCCM)
     

    Physicians: Accreditation for Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Society of Critical Care Medicine (SCCM) and AKH Inc., Advancing Knowledge in Healthcare. The Society of Critical Care Medicine (SCCM) is accredited by the ACCME to provide continuing medical education for physicians.
    Designation Statement: The Society of Critical Care Medicine designates this enduring educational activity for a maximum of .5 AMA PRA Category 1 credits™. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
     
    Physician Assistants: The American Academy of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education or a recognized state medical society. Physician assistants may receive a maximum of .5 Category 1 credits for completing this activity.
     
    Pharmacists: The Society of Critical Care Medicine (SCCM) is accredited by the Accreditation 
    Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This course (0236-9999-17-302-H01-P) provides up to .5 contact hours of continuing education. SCCM reports to a continuing pharmacy education (CPE) tracking service, CPE Monitor, using your National Association of Boards of Pharmacy (NABP) member number and date of birth. You are responsible for providing accurate information to SCCM  and submitting your data within 60 days from participating in the activity. CPE Monitor will authenticate and store data for completed CPE units received by pharmacists and pharmacy technicians.
     
    CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare- Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and The Society of Critical Care Medicine (SCCM).
     
    Nurses
    AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
    This activity is awarded 0.5 Contact Hours.
     
    Method of Participation Statements of credit will be awarded based on the participant reviewing the entire presentation, scoring a 70% on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. If you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com
     
    Faculty Disclosures
    Dr. Benbadis has disclosed the following relevant financial relationships:
    Consultant: Acorda Therapeutics, Cyberonics, Inc., Eisai, Lundbeck, Sunovion, UCB, Inc., Upsher-Smith
    Contracted Research: Acorda Therapeutics, Cyberonics, Inc., GW, Lundbeck, Sepracor, Inc., Sunovion, UCB, Inc., Upsher-Smith
    Speakers Bureau: Cyberonics, Inc. (Livanova), Eisai, Lundbeck, NeuroPace, Inc., Sunovion, UCB, Inc.
     
    Dr. Hantus discloses no financial relationships with pharmaceutical or medical product manufacturers.
     
    Accredited Provider Disclosure
    STAFF/REVIEWERS
    Margaret V. Clark, MSc, RN, RRT - NPS, CMPP, Medical Writer/Interviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
     
    Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.
     
    SCCM and AKH Inc, planners and reviewers have disclosed no financial relationships with pharmaceutical or medical product manufacturers.
     
    Commercial Support 
    This activity is supported by an educational grant from UCB, Inc.
     
    Fee
    There is no fee to participate in this activity
     
    Disclaimer
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
     
    Disclosure of Unlabeled Use and Investigational Product
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    Disclosure Declaration
    It is the policy of SCCM and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by SCCM and AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.  SCCM & fAKH planners and reviewers have no relevant financial relationships to disclose.
     
    This activity is endorsed by:
     
    Credit provided by: 
     and 
     
    Copyright © 2017 No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publishe
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
     
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above.



     
     

    AKH Inc., Advancing Knowledge in Healthcare
    PO Box 24104
    Jacksonville, FL 32241-4104
    Service@akhcme.com
    904.683.8843
    866.352.6285 (fax)

    AKH Privacy Policy